LINDSAY PARSONS: Open Payments
NPI 1760580179 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$305 in 33 payments from 4 companies in 2025. Trend: 2023 $224 · 2024 $236 · 2025 $305
Food & beverage: $305
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 25 | $142 |
| ABBVIE INC. | 6 | $129 |
| BLUEWIND MEDICAL | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
Products named: GEMTESA, BOTOX, REVI, Veozah.
Industry payments across TX — which companies pay providers there.
